Complete Guide to Metabolic Research Peptides UK

Metabolic research peptides have attracted unprecedented scientific attention following landmark publications on GLP-1 receptor agonists. This guide covers the major categories of metabolic research compounds, their mechanisms and published research profiles.

GLP-1 Receptor Agonists: Semaglutide and Liraglutide are synthetic analogues of endogenous GLP-1 (Glucagon-like Peptide-1). Research has examined their mechanisms of action on pancreatic beta cells, hypothalamic appetite centres, gastric emptying and cardiovascular tissue. The SUSTAIN, STEP and LEADER trial series have generated thousands of published papers. GLP-1 peptide itself is also studied for mechanistic receptor research.

Dual Incretin Agonist: Tirzepatide activates both GIP and GLP-1 receptors simultaneously. Research examines the additive contribution of GIP receptor co-activation, with published data suggesting dual agonism produces differential metabolic outcomes compared to GLP-1 mono agonism. The SURMOUNT trial series has generated extensive comparative data.

HGH Fragment: AOD-9604 (hGH176-191) is studied for its selective lipolytic effects via beta-3 adrenergic receptor stimulation. Research has demonstrated fat metabolism effects without IGF-1 elevation or glucose metabolism interference, making it of interest for isolated fat tissue metabolism research.

GHRH Analogue: Tesamorelin is a GHRH analogue studied for GH stimulation and visceral adipose tissue reduction in research models, with a well-established clinical research literature.

Other metabolic compounds in our catalogue include 5-Amino-1MQ (NNMT inhibitor), GLP-1 peptide and various GH secretagogues with metabolic research applications. All supplied at 99%+ HPLC purity for research use only.

⚠️ Research Disclaimer: This guide is for informational and scientific research context only. All UK Peptides compounds are sold strictly for laboratory research. Not for human consumption.